The purpose of this study was to analyze medical late effects among patients with chronic
myeloid leukemia (CML) treated with hematopoietic cell transplantation (HCT). Subjects …

Abstract The Bone Marrow Transplant Survivor Study is a retrospective cohort study in which
participants who received hematopoietic cell transplantation (HCT) between 1974 and 1998 …

We assessed late mortality in 1479 individuals who had survived 2 or more years after
allogeneic hematopoietic cell transplantation (HCT). Median age at HCT was 25.9 years and …

Long-term morbidity after hematopoietic cell transplantation (HCT) is unknown. The risk of
physical and psychological health in 324 patients who had survived 10 or more years after …

Purpose To determine late effects of hematopoietic cell transplantation (HCT) on health
problems and health-related quality of life for 10-year survivors. Patients and Methods Four …

Long-term survival is now an expected outcome after hematopoietic cell transplantation
(HCT). However, the burden of morbidity long-term after HCT remains unknown. We …

The high intensity of therapy and prolonged immune suppression after hematopoietic cell
transplantation (HCT) increase the risk of long-term complications and health care needs …

Purpose Our objective was to describe the incidence of nonmalignant late complications
and their association with health and functional status in a recent cohort of hematopoietic …

We assessed late mortality in 854 individuals who had survived 2 or more years after
autologous hematopoietic cell transplantation (HCT) for hematologic malignancies. Median …

Background and objective: As long‐term survivors of hematopoietic cell transplantation
(HCT) become more numerous, studies addressing the issue of long‐term follow‐up are …